Data on valve durability with transcatheter aortic valve replacement are reassuring at 7 years, with implications for ...

TriCares announced today that it enrolled the first patient in its TRICURE US FDA investigational device exemption (IDE) ...

Jenscare Scientific announced today that it received CE mark approval for its LuX-Valve plus under EU Medical Device ...

Initiation of the TRICURE US IDE pivotal study represents the first of next-generation TTVR devices to enroll patients in the ...

The Ross procedure for aortic valve replacement, which involves a pulmonary valve autograft, achieved low rates of ...

Nyra Medical, Inc., a clinical-stage medical technology company developing a novel transcatheter solution for functional ...

Our multidisciplinary cardiovascular team collaborates on mitral valve repair, transcatheter technologies, mitral valve replacement, and follow-up treatment so patients can get all their care for ...

Heart valves can be replaced with open heart surgery or with less invasive procedures that don’t require your chest to be opened. Known as transcatheter valve replacement, this type of procedure has ...

Mortality at 30 days was deemed “acceptable” after valve-in-valve and valve-in-ring procedures, but “high” after valve-in-MAC ...

Replacing a faulty heart valve can restore healthy circulation, but the procedure carries some risks. These include blood clots, infection, and other complications. Generally, the outlook is usually ...